Hofseth BioCare ASA (HBC)
produces CalGo®, a microcrystalline hydroxyapatite form of calcium,
which is a highly bioavailable calcium supplement with more than 24
% fish bone collagen.
Calcium is an essential
mineral that supports bone and joint health. It is used as a
supplement, most typically as calcium carbonate, to assist in
preserving bone density especially when dietary calcium intake is
inadequate. In the present study we examined the effect of five
varied calcium sources, three natural and two synthetic, on
stimulation, proliferation and mineralization of cultured human
osteoblast cells.
A recent In Vitro Study on
the Effect of Five Commercial Calcium Supplements on Human
Osteoblast Cell Proliferation and Ca2+ Mineralization has been
published in the Journal of Nutrition & Food
Sciences (J Nutr Food Sci 8: 738. doi:
10.4172/2155-9600.1000738). The results of this study validate
previous dietary studies that show that consuming small fish bones
in the diet improves bone and joint health and that natural fish
bone supplements, such as CalGo® (salmon bone collagen calcium),
may serve as a superior, bioavailable calcium supplement as
compared to other mono-component organic or inorganic calcium
supplement powders.
The improved effect is
likely due to several factors; the presence of calcium in its
phosphorus-rich hydroxyapatite form, the presence of
bone-supporting micronutrient minerals and their influence on
alkaline phosphatase activity and the presence of type II collagen
that helps increase DNA synthesis and proliferation and Ca2+
deposition in human osteoblast cells.
Hofseth BioCare ASA is
introducing Nøre Nutrition AS as its new sales company to focus
more on direct B2C sales, and social media marketing. The first
product to be launched is "Marint Kalsium",
as part of the companies' focus to deliver quality of life to its
customers. With the use of CalGo® as its main ingredient, Nøre will
have the best calcium available on the market as its first
product.
Read the full article here:
hofsethbiocare.com/upload_images/D2CA82B1D7164AC18C1AA48ED49675F4.pdf
For further information,
please contact:
Roger Hofseth, CEO of
Hofseth BioCare ASA
Mob: +47 95147941
E-mail:
rh@hofseth-as.no
Kai Morten Thuen, CEO of
Nøre Nutrition AS
Mob: +47 91638401
E-mail:
kmt@hofsethbiocare.no
About Hofseth BioCare
ASA:
HBC is a Norwegian biotech
company that offers high-value ingredients and finished products
for humans and pets. The company is founded on the core values of
sustainability, traceability and optimal utilization of natural
resources. Through an innovative hydrolysis technology, HBC is able
to preserve the quality of salmon oil, proteins and calcium,
prepared of fresh salmon off-cuts. HBC's objective is to contribute
to the efficient use of marine resources and deliver quality
products for ingredients and finished consumer products in the
nutrition market.
Hofseth BioCare's
headquarters are located in Ålesund, Norway with branches in Oslo,
Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange
Axess list with ticker "HBC". More information about Hofseth
BioCare at www.hofsethbiocare.com and
www.facebook.com/hofsethbiocare
About Nøre Nutrition
AS:
Nøre is a fully owned B2C
sales and marketing company of Hofseth BioCare ASA. The company's
strategy is to deliver quality of life to its customers by using
HBC ingredients, and developing new exiting and valuable product
for its customers. Nøre Nutriotion's headquarter is in Ålesund,
Norway. More information at https://www.facebook.com/norenutrition/
and http://nore-nutrition.no/
This information is subject
to the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.